From: CD163 versus CD68 in tumor associated macrophages of classical hodgkin lymphoma
Demographics | Clinical Characteristics | Immunohistochemical Analysis2 | Â | ||||
---|---|---|---|---|---|---|---|
Patient | Age | Sex | Stage | Tumor size (cm)1 | CD68 | CD163 | p value |
1 | 21 | F | IIA | 6 | 2 | 1 | 0.01 |
2 | 73 | M | IIIB | 3 | 2 | 1 | Â |
3 | 37 | M | IIA | 2 | 3 | 2 | Â |
4 | 59 | F | IIA | 4.3 | 3 | 3 | Â |
5 | 42 | F | IIA | 4 | 3 | 3 | Â |
6 | 94 | M | IIA | 2.2 | 3 | 1 | Â |
7 | 20 | F | IIIA | > 10 | 2 | 1 | Â |
8 | 19 | F | IIA | > 10 | 3 | 3 | Â |
9 | 51 | M | IVA | > 10 | 3 | 3 | Â |
10 | 28 | M | IIA | 2.5 | 2 | 1 | Â |
11 | 33 | F | IVB | 3 | 2 | 2 | Â |
12 | 62 | F | IIB | 2 | 2 | 2 | Â |
13 | 15 | F | IIIA | > 10 | 2 | 2 | Â |
14 | 22 | M | IIA | 2 | 1 | 1 | Â |
15 | 23 | F | IIB | > 10 | 1 | 1 | Â |
16 | 33 | M | IA | 2.8 | 2 | 2 | Â |
17 | 48 | M | IB | 3 | 2 | 2 | Â |
18 | 17 | F | IVB | 5 | 2 | 2 | Â |
19 | 25 | F | IIB | 17 | 1 | 1 | Â |
20 | 52 | M | IVB | 4 | 3 | 3 | Â |
21 | 45 | M | IVB | 11 | 2 | 1 | Â |
22 | 20 | M | IIB | 2 | 3 | 3 | Â |
23 | 64 | M | IVB | 5.5 | 1 | 1 | Â |
24 | 23 | M | IIA | 4 | 3 | 3 | Â |
25 | 14 | M | IVB | 9.4 | 2 | 2 | Â |
26 | 14 | F | IVB | 3 | 1 | 1 | Â |
27 | 35 | M | IIA | 1.8 | 2 | 1 | Â |
28 | 54 | M | IIIB | 4.9 | 2 | 1 | Â |
29 | 40 | M | IV | 2.2 | 3 | 1 | Â |
30 | 21 | F | IA | 10 | 3 | 3 | Â |
31 | 34 | F | IA | 6.3 | 2 | 2 | Â |
32 | 17 | F | IVB | 5.1 | 2 | 3 | Â |
33 | 22 | F | IIB | 7.5 | 2 | 2 | Â |
34 | 66 | F | IIIA | 1.7 | 2 | 2 | Â |
35 | 26 | F | IVA | 1.6 | 1 | 1 | Â |
36 | 24 | M | IV | 6.3 | 2 | 2 | Â |
37 | 35 | M | IIA | 1.5 | 3 | 3 | Â |
38 | 23 | F | IIA | 2.5 | 3 | 3 | Â |
39 | 26 | M | IVB | 2.3 | 2 | 2 | Â |
40 | 18 | F | IIIA | 6 | 1 | 2 | Â |
41 | 49 | M | IA | 9 | 2 | 2 | Â |
42 | 70 | F | IVB | 2.4 | 2 | 1 | Â |
43 | 21 | M | IIA | 3 | 1 | 1 | Â |
44 | 38 | M | IA | 4 | 3 | 3 | Â |